EKO ANNOUNCES 750,000 DEVICES SOLD

CLAIM OFFER

Eko's Recent Milestone Signals Rapid Adoption of Digital Stethoscopes

AI early disease detection company Eko Health announces 750,000 digital stethoscopes sold worldwide, underscoring a defining shift in modern clinical care: the analog stethoscope is rapidly giving way to a smarter, more connected standard.

Breaking News in Healthcare AI

May 31, 2026

Not long ago, the idea of a digital stethoscope was met with skepticism. Clinicians had used the same basic tool for more than 200 years. It was fine, so why change it?

 

The problem — over 60% of heart diseases go undiagnosed .1

 

Eko set out to solve that problem with a digital stethoscope that could do what an antiquated analog device never could — amplify sound, visualize cardiac waveforms, and layer AI-powered detection on top of a provider's own judgment.


The clinical community took notice. With 9 FDA clearances for devices and algorithms, over 70 peer-reviewed studies, and major health system partners that have integrated Eko into their standard of care, it's not surprising that 750,000 devices have been sold worldwide.

"When we shipped our first stethoscope, we hoped providers would see what we saw — that digital wasn't just different, it was necessary for better care. 750,000 devices later, they've made that case better than we ever could. Those devices now touch tens of millions of patients every year, helping care teams make informed, confident decisions."

Connor Landgraf, Eko Co-founder and CEO

And today, providers who use Eko are 2x more likely to detect heart disease.2

 

Emergency departments, primary care offices, cardiology practices, medical schools, and more have all made the transition. The clinicians leading that shift aren't early adopters chasing new technology — they're pragmatists who found that digital simply produced better results. Patients are being diagnosed earlier. Conditions that would have been missed are being caught. And a generation of new clinicians is entering the field, having never trained on anything but digital.

Why the transition from analog to digital is accelerating:

  • Better tools produce better results. Clinicians using digital stethoscopes are twice as likely to detect heart disease at the point of care.2
  • It fits the pace of modern medicine. Real-time AI analysis means faster decisions — no additional tests, no referrals, no delays.
  • It's a second opinion that's always available. In high-pressure environments, AI-backed insight at the point of care gives clinicians the confidence to act.

When you have better tools, you can provide better care. 

EXPLORE EKO

1. Gardezi SKM, SENN O, Hunziker L, et al. Cardiac auscultation in diagnosing valvular heart disease: a comparison between general practitioners and cardiologists. Eur Heart J. 2017;38:1155.

2. Rancier, M. A., Israel, I., Monickam, V., Prince, J., Verschoore, B., & Currie, C. (2023). Real World Evaluation of an Artificial Intelligence Enabled Digital Stethoscope for Detecting Undiagnosed Valvular Heart Disease in Primary Care. Circulation, 148, A13244.